The iShares Russell 2000 ETF (IWO) is rated a sell because it is heavily weighted towards unprofitable small-cap stocks, especially in biotech, with 36% of holdings losing money and a high forward price-to-earnings ratio of 25.5x. Although the fund projects a 58% forward earnings growth, much of this comes from currently unprofitable companies expected to turn profitable, while already profitable firms show only 15% growth. Additionally, about 12% of the fund's assets have no analyst coverage, increasing risk. Technical indicators also suggest further downside, with weak momentum and price below key moving averages, leading to a recommendation to avoid IWO.
The iShares Russell 2000 ETF (IWO) is discussed here, with Pluang market data providing context. Of 150 US stocks tradable on Pluang, 113 rose and 36 fell today. Notable movers include ASX at USD 44.46 with a 6.80% gain, AMC at USD 2.88 up 6.67%, and MRVL at USD 260.18 rising 6.52%, as of Sep 22, 2026 08:41 WIB.
Major investment funds are increasingly concerned that AI exposure across sectors reduces traditional diversification benefits, prompting interest in Bitcoin as a potential hedge. Bitcoin's recent strong price performance and low, unpredictable corre...
Tempus AI's stock surged 60%, fueled by a 31% year-over-year increase in oncology testing volumes and nearly doubled MRD test volumes since Q4 2025, validating its acquisition of Personalis. The company's data and applications segment grew 28% in Q2,...
Taiwan's Taiex index reached a record intraday high of 48,601.53 driven by strong gains in the tech sector, especially semiconductor companies like TSMC, MediaTek, and Delta Electronics. This surge follows an AI-driven rally on Wall Street fueled by ...
China's lithium carbonate and spodumene spot prices fell significantly over the past month, influenced by the loss of license at CATL's Jianxiawo Mine, the country's largest lithium mine, which has returned to care and maintenance. Despite the price ...
Zcash (ZEC) price pulled back from a September peak near $1,590 to about $1,430, pausing after a strong rally. Institutional interest remains high, supported by Grayscale's Zcash ETF and a planned share split. The main issue is a debate over the Zcas...
